OUTSET MEDICAL INC

Trigg Leslie’s August 17 sell‑to‑cover of 3,437 Outset Medical shares shows routine tax‑cover activity, not a bearish signal, highlighting the CEO’s long‑term ownership strategy.

Outset Medical insider John L. Brottem’s routine sell‑to‑cover of 2,632 shares shows steady confidence, not market timing.

Insider buying spurs optimism for Outset Medical as Patrick H. Hackett and execs pile up shares amid a steep 78% drop, hinting at undervaluation and a potential rebound.

Outset Medical insider buying signals optimism amid a bearish trend—Kevin O’Boyle’s June 2026 purchase hints at undervalued potential and a possible upcoming product launch.

Insider buying continues at Outset Medical – Leonard Braden Michael’s new purchase shows cautious confidence amid a steep 81 % share decline and a negative P/E, signaling potential upside for investors.

Insider buying shows confidence in Outset Medical’s growth, with EVP Commercial Elliott Derick’s RSU grant hinting at future hemodialysis expansion and potential upside.

Outset Medical insider selling spikes: 1.9 M shares off the books after earnings, 24% drop, 38% monthly loss—what it signals for investors and the company’s valuation.

Outset Medical’s insider sell‑to‑cover by EVP Nash Marc shows routine tax liquidity, not a confidence shift, amid a 26 % weekly rally and rising social‑media buzz.